[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Hyperkalemia Market: A BCC Research Perspective

January 2020 | 19 pages | ID: H06A5B3C479DEN
BCC Research

US$ 1,250.00 US$ 2,500.00 -50 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

The goals of this study were to understand the current market scenario for hyperkalemia drugs and to assess the market’s growth potential through the end of 2022. This study explores market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current market for hyperkalemia and the future direction of the market.
CHAPTER 1 INTRODUCTION

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Analyst's Credentials
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

Highlights

CHAPTER 3 DISEASE BACKGROUND AND MARKET DYNAMICS

Disease Background
Overview
Pathogenesis
Diagnosis
Epidemiology
Treatment
Market Dynamics
Market Drivers
Market Restraints

CHAPTER 4 MARKET BREAKDOWN BY SEVERITY

Mild Hyperkalemia
Market Size and Forecast
Moderate Hyperkalemia
Market Size and Forecast
Severe Hyperkalemia
Market Size and Forecast

CHAPTER 5 COMPANY PROFILES

ARDELYX
ASTRAZENECA PLC
VIFOR PHARMAList of Tables
Summary Table : Global Hyperkalemia Market, by Severity, Through 2022
Table 1 : Global Hyperkalemia Market, Through 2022
Table 2 : Global Hyperkalemia Market, by Severity, Through 2022List of Figures
Summary Figure : Global Hyperkalemia Market Share, by Severity, 2018
Figure 1 : Global Hyperkalemia Market Share, by Severity, 2018
Figure 2 : Global Mild Hyperkalemia Market, 2018-2022
Figure 3 : Global Moderate Hyperkalemia Market, 2018-2022
Figure 4 : Global Severe Hyperkalemia Market, 2018-2022


More Publications